Your session is about to expire
← Back to Search
Therapeutic Conventional Surgery for Anaplastic Astrocytoma
Study Summary
This trial is testing a new virus treatment for brain cancer. The virus is made to only attack cancer cells, and not healthy cells.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My tumor can be removed surgically, and I need a surgery to remove part of my skull to access it.My recurrent brain tumor does not have IDH-1 mutation and shows a significant mass on MRI.It has been at least 8 weeks since my last radiotherapy session.My IDH-mutant astrocytoma has progressed to grade 4 at recurrence with a significant mass visible on MRI.My tumor is between 1.0 cm and 5.0 cm in size.My cancer has spread to the lining of my brain and spinal cord.I have trouble getting IV lines placed for procedures.I haven't had biologic or immunotherapy in the last 2 weeks.My tumor is located in the back part of my brain.My brain tumor is not classified as GBM, gliosarcoma, IDH wild-type grade III, or IDH-mutant grade 4 astrocytoma.My cancer has spread to the lower part of my brain or outside my skull.I have a health condition that prevents me from having surgery.I agree not to take other cancer treatments while in this study.I do not have any severe infections or unstable health conditions.I don't have any health or mental conditions that would stop me from joining.I have a brain infection or condition like encephalitis or multiple sclerosis.I haven't received blood transfusions or medications for blood disorders in the last 28 days.I am mostly independent and can care for myself.My artery is less than 50% blocked and can be treated with a procedure.My cancer has returned or worsened after treatment, confirmed by an MRI.My bone marrow, liver, and kidneys are working well.I have Li-Fraumeni Syndrome or a genetic issue related to the retinoblastoma gene.My condition is recurrent GBM or gliosarcoma.I am 18 years old or older.I can follow the study's requirements and stick to the treatment plan.I have a blood clotting disorder or a primary blood disease.I have a bleeding disorder or am taking blood thinners.I've finished certain chemotherapies and recovered from major side effects.I have a weakened immune system or an autoimmune condition.I have signs of an inflammatory or autoimmune condition.
- Group 1: Part II (oncolytic adenovirus Ad5-DNX-2401, surgery)
- Group 2: Part I (oncolytic adenovirus Ad5-DNX-2401)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA given sign-off to Therapeutic Conventional Surgery?
"The safety of Therapeutic Conventional Surgery is estimated to be a 1 given the limited evidence currently available. This is supported by its Phase 1 trial status, which suggests few studies have been conducted on efficacy and safety."
Are there any spots open to join this research endeavor?
"Affirmative. According to the information found on clinicaltrials.gov, this medical study is actively recruiting participants since its posting date on February 12th 2019 and latest update on August 11th 2022. This clinical trial seeks 36 patients from one location specifically."
How many individuals can enrol in this clinical experiment?
"Affirmative. As reported on clinicaltrials.gov, this medical trial is presently recruiting participants and was first posted on February 12th 2019 with the most recent edit being made on August 11th 2022. The research team needs to enroll 36 patients from one centre."
Share this study with friends
Copy Link
Messenger